Steven Feldman to Boron Compounds
This is a "connection" page, showing publications Steven Feldman has written about Boron Compounds.
Connection Strength
2.783
-
Stein Gold LF, Takiya L, Zang C, Sanders P, Feldman SR. Demographics and Baseline Disease Characteristics of Early Responders to Crisaborole for Atopic Dermatitis. J Drugs Dermatol. 2020 Jun 01; 19(6):619-624.
Score: 0.717
-
Howell AN, Ghamrawi RI, Strowd LC, Feldman SR. Pharmacological management of atopic dermatitis in the elderly. Expert Opin Pharmacother. 2020 May; 21(7):761-771.
Score: 0.704
-
Jackson DG, Cardwell LA, Oussedik E, Feldman SR. Utility of boron in dermatology. J Dermatolog Treat. 2020 Feb; 31(1):2-12.
Score: 0.687
-
Moustafa F, Feldman SR. A review of phosphodiesterase-inhibition and the potential role for phosphodiesterase 4-inhibitors in clinical dermatology. Dermatol Online J. 2014 May 16; 20(5):22608.
Score: 0.472
-
Ramachandran V, Cline A, Feldman SR, Strowd LC. Evaluating crisaborole as a treatment option for atopic dermatitis. Expert Opin Pharmacother. 2019 Jun; 20(9):1057-1063.
Score: 0.166
-
Edwards T, Patel NU, Blake A, Prabakaran S, Reimer D, Feldman SR, Strowd LC. Insights into future therapeutics for atopic dermatitis. Expert Opin Pharmacother. 2018 02; 19(3):265-278.
Score: 0.038